Castle biosciences shares new data demonstrating ability of tissuecypher® test results to inform clinical decision-making in patients with non-dysplastic barrett's esophagus

Friendswood, texas--(business wire)---- $cstl #barrettsesophagus--new data shows the ability of tissuecypher® test results to inform clinical decision-making in patients with non-dysplastic barrett's esophagus.
CSTL Ratings Summary
CSTL Quant Ranking